BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21062408)

  • 1. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
    Taylor F; Murphy S; Hoather T; Dobson J; Scase T
    Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
    Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
    Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of prostaglandin E2 and vascular endothelial growth factor in canine cutaneous mast cell tumours.
    Amorim RL; Pinczowski P; Neto RT; Rahal SC
    Vet Comp Oncol; 2010 Mar; 8(1):23-7. PubMed ID: 20230578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
    Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
    Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
    Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
    Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
    Munday JS; French AF; Gibson IR; Gwynne K
    Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
    Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
    Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
    Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
    J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment.
    Teng SP; Hsu WL; Chiu CY; Wong ML; Chang SC
    Vet J; 2012 Aug; 193(2):551-6. PubMed ID: 22398132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSLC1 gene silencing in cutaneous melanoma.
    You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
    Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling.
    Pulz LH; Barra CN; Alexandre PA; Huete GC; Cadrobbi KG; Nishiya AT; de Freitas SH; Fukumasu H; Strefezzi RF
    PLoS One; 2019; 14(6):e0217343. PubMed ID: 31216299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
    Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
    J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.